Table 3.
Total femur BMDa β±SE | p value | |
---|---|---|
Model R2 | 44.2 % | |
Age | −0.0013±0.0003 | <0.001* |
Gender | −0.0705±0.0040 | <0.001* |
Ethnicity | <0.001* | |
Mexican (ref) | – | |
Hispanic and other | 0.0065±0.0076 | |
White | −0.0006±0.0047 | |
Black | 0.0355±0.0049 | |
BMI | 0.0063±0.0003 | <0.001* |
HRT | 0.0573±0.0075 | <0.001* |
Physical activity | 0.006* | |
None (ref) | – | |
Moderate | 0.0075±0.0033 | |
Vigorous | 0.0198±0.0058 | |
Alcohol consumption | <0.001* | |
<1 drink/month or unknown (ref) | – | |
≥1 drink/month and <1 drink/week | 0.0156±0.0036 | |
≥1 drink/week and <1 drink/day | 0.0166±0.0050 | |
≥1 drink per day | 0.0125±0.0065 | |
Smoking status | 0.022* | |
Never (ref) | – | |
Former | −0.0042±0.0034 | |
≤1 pack per day | −0.0171±0.0072 | |
>1 pack per day | −0.0309±0.0105 | |
Dietary magnesiuma | 0.0074±0.0030 | 0.018* |
Marine derived dietary omega 3a | −0.0011±0.0179 | 0.950 |
HRT hormone replacement therapy use, BMI body mass index
p ≤0.05
Total femur BMD square root transformed; dietary magnesium cube root transformed, marine-derived dietary omega 3 presented as the log of reported intakes plus 1 to correct for distribution skewness